sinc
discoveri
saudi
arabia
middl
east
respiratori
syndrom
coronaviru
merscov
implic
laboratori
confirm
case
human
infect
includ
death
among
case
report
european
countri
includ
import
case
local
persontoperson
transmiss
merscov
genom
compris
least
put
open
read
frame
includ
encod
spike
nucleocapsid
n
protein
n
protein
gene
use
coronaviru
genotyp
phylogenet
analys
aid
understand
viru
tempor
geograph
origin
evolut
protein
involv
viru
receptor
bind
known
main
antigen
compon
signific
neutral
antibodi
respons
induc
n
protein
highli
immunogen
phosphoprotein
implic
viral
genom
replic
modul
cell
signal
pathway
present
studi
focus
laboratori
investig
import
merscov
case
greec
phylogenet
comparison
recent
circul
strain
greek
nation
present
tertiari
care
hospit
athen
april
prolong
fever
diarrhea
pneumonia
onset
symptom
april
arriv
hour
earlier
jeddah
saudi
arabia
resid
perman
high
suspicion
merscov
infect
two
oropharyng
swab
specimen
collect
april
specimen
april
specimen
b
laboratori
investig
purpos
urgent
clinic
care
test
need
explain
patient
written
consent
obtain
potenti
public
molecular
detect
merscov
rna
two
realtim
rtpcr
rrtpcr
assay
target
region
upstream
envelop
gene
upe
open
read
frame
orf
use
partial
sequenc
rnadepend
rna
polymeras
rdrp
n
gene
blast
analysi
amplicon
sequenc
also
perform
previous
describ
serum
sampl
collect
patient
six
day
hospit
avail
serolog
test
use
antim
coronaviru
indirect
immunofluores
kit
euroimmun
lubeck
germani
addit
partial
sequenc
full
length
orf
nt
n
nt
protein
gene
obtain
center
diseas
control
prevent
cdc
atlanta
ga
use
sanger
sequenc
method
deposit
genbank
databas
access
number
respect
sequenc
confirm
independ
two
separ
cdc
laboratori
upe
rrtpcr
result
specimen
equivoc
pcr
threshold
cycl
ct
valu
neg
respect
specimen
determin
inconclus
merscov
rna
detect
contrast
specimen
b
found
posit
upe
assay
ct
valu
respect
presenc
merscov
rna
also
confirm
specimen
b
rtpcr
partial
sequenc
rdrp
n
gene
full
genom
sequenc
possibl
due
limit
avail
sampl
volum
howev
sequenc
n
protein
code
region
success
obtain
greecesaudi
differ
nucleotid
nt
amino
acid
aa
publish
human
camel
deriv
merscov
sequenc
one
uniqu
nt
chang
present
mix
base
posit
g
c
orf
confer
predict
aa
chang
arginin
r
prolin
p
posit
greecesaudi
n
differ
nt
aa
publish
merscov
sequenc
uniqu
nt
chang
identifi
phylogenet
analys
merscov
n
orf
shown
fig
greecesaudi
sequenc
cluster
close
human
deriv
merscov
strain
obtain
jeddah
makkah
saudi
arabia
april
merscov
sequenc
recent
obtain
dromedari
camel
saudi
arabia
qatar
also
cluster
greecesaudi
sequenc
serolog
identifi
specif
antimercov
igm
titer
igg
titer
antibodi
patient
serum
sampl
present
studi
describ
laboratori
investig
import
merscov
case
greec
discrep
rrtpcr
result
specimen
b
may
due
differ
sampl
techniqu
although
detect
attribut
increas
viral
load
infect
progress
rule
specimen
b
collect
addit
specimen
particularli
lower
respiratori
tract
differ
time
point
diseas
cours
highli
recommend
strong
clinic
epidemiolog
suspicion
merscov
infect
initi
result
upper
respiratori
tract
specimen
neg
inconclus
drosten
et
al
point
copiesml
merscov
rna
present
lower
respiratori
tract
specimen
wherea
small
amount
viral
rna
could
detect
upper
respiratori
tract
specimen
accord
world
health
organ
recommend
partial
sequenc
rdrp
n
gene
accept
altern
confirm
merscov
infect
although
rtpcr
partial
gene
sequenc
method
time
consum
found
approach
help
resolv
discrep
rtpcr
result
detect
merscovspecif
antibodi
patient
serum
consist
recent
merscov
infect
ideal
howev
serolog
confirm
acut
merscov
infect
second
serum
specimen
taken
two
week
onset
ill
also
test
find
reveal
genom
subpopul
swab
sampl
possess
uniqu
amino
acid
substitut
protein
receptorbind
domain
rbd
compar
publish
human
camel
sequenc
substitut
confirm
independ
two
separ
cdc
laboratori
rule
possibl
introduct
rtpcr
substitut
locat
within
region
residu
merscov
rbd
directli
interact
dipeptidyl
receptor
host
cell
surfac
viral
attach
recent
mutagenesi
studi
indic
alter
key
residu
within
region
ie
shown
significantli
reduc
bind
viral
entri
effici
studi
indic
substitut
littl
effect
bind
affin
rbd
studi
need
clarifi
whether
substitut
arginin
prolin
posit
identifi
present
studi
function
implic
phylogenet
analysi
reveal
greek
strain
close
relat
jeddah
makkah
strain
circul
recent
burst
merscov
activ
arabian
peninsula
consist
assumpt
patient
might
acquir
infect
commun
altern
nosocomialenviron
visit
local
hospit
jeddah
repeatedli
sinc
begin
april
moreov
cluster
greek
n
orf
sequenc
dromedari
camel
accord
recent
find
confirm
similar
human
camel
merscov
sequenc
identifi
geograph
area
ongo
outbreak
merscov
suggest
risk
import
viru
countri
expect
continu
although
number
incid
case
steadili
declin
respect
fast
reliabl
laboratori
confirm
crucial
time
implement
infect
control
measur
prevent
secondari
person
person
transmiss
